Dexmedetomidine for the treatment of hyperactive delirium refractory to haloperidol in nonintubated ICU patients: A nonrandomized controlled trial

Critical Care Medicine

Volumn 44, Issue 7, 2016, Pages 1295-1306

  Carrasco, Genís ^a   Baeza, Nacho ^a   Cabré, Lluís ^a   Portillo, Eugenia ^a   Gimeno, Gemma ^a   Manzanedo, David ^a   Calizaya, Milagros ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

cost benefit analysis; delirium; dexmedetomidine; haloperidol; nonintubated patients; nonrandomized controlled trial; psychomotor agitation

Indexed keywords

DEXMEDETOMIDINE; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT;

AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; CRITICALLY ILL PATIENT; DRUG COST; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE PSYCHOSIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT PROLONGATION; RICHMOND AGITATION SEDATION SCALE; SEDATION; SIDE EFFECT; DELIRIUM; DRUG RESISTANCE; ECONOMICS; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PSYCHOMOTOR AGITATION; RISK FACTOR;

AGED; ANTIPSYCHOTIC AGENTS; COST-BENEFIT ANALYSIS; DELIRIUM; DEXMEDETOMIDINE; DRUG COSTS; DRUG RESISTANCE; FEMALE; HALOPERIDOL; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; LENGTH OF STAY; MIDDLE AGED; PSYCHOMOTOR AGITATION; RISK FACTORS;

EID: 84959258761     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001622     Document Type: Article

References (39)

1. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999; 27:1325-1329
2. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291:1753-1762
3. Bergeron N, Dubois MJ, Dumont M, et al. Intensive Care Delirium Screening Checklist: Evaluation of a new screening tool. Intensive Care Med 2001; 27:859-864
4. Ely EW, Girard TD, Shintani AK, et al. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med 2007; 35:112-117
5. Lin SM, Liu CY, Wang CH, et al. The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med 2004; 32: 2254-2259
6. Barr J, Pandharipande PP. The pain, agitation, and delirium care bundle: Synergistic benefits of implementing the 2013 Pain, Agitation, and Delirium Guidelines in an integrated and interdisciplinary fashion. Crit Care Med 2013; 41:S99-S115
7. Celis-Rodríguez E, Birchenall C, de la Cal MA, et al; Federación Panamericana e Ibérica de Sociedades de Medicina Crítica y Terapia Intensiva: Clinical practice guidelines for evidence-based management of sedoanalgesia in critically ill adult patients. Med Intensiva 2013; 37:519-574
8. Skrobik Y. Haloperidol should be used sparingly. Crit Care Med 2002; 30:2613-2614
9. Dumont M, Gottfried S B. Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med 2004; 30:444-449
10. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38:419-427
11. Girard TD, Pandharipande PP, Carson SS, et al; MIND Trial Investigators: Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Crit Care Med 2010; 38:428-437
12. Skrobik YK, Bergeron N, Dumont M, et al. Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med 2004; 30:444-449
13. Lonergan E, Britton AM, Luxenberg J, et al. Antipsychotics for delirium. Cochrane Database Syst Rev 2007; 2:CD005594
14. Reade MC, O'Sullivan K, Bates S, et al. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: A randomised openlabel trial. Crit Care 2009; 13:R75
15. Maldonado JR, Wysong A, van der Starre PJ, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 2009; 50:206-217
16. Yapici N, Coruh T, Kehlibar T, et al. Dexmedetomidine in cardiac surgery patients who fail extubation and present with a delirium state. Heart Surg Forum 2011; 14:E93-E98
17. van den Boogaard M, Pickkers P, Slooter AJ, et al. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICU patients) delirium prediction model for intensive care patients: Observational multicentre study. BMJ 2012; 344:e420
18. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Am J Resp Crit Care Med 2002; 166:1338-1344
19. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286:2703-2710
20. Carrasco G, Pallarés A, Cabré L: [Cost of quality in Intensive Medicine. Guidelines for clinical management]. Med Intensiva 2006; 30:167-179
21. Armstrong R, Waters E, Moore L, et al. Improving the reporting of public health intervention research: Advancing TREND and CONSORT. J Public Health (Oxf) 2008; 30:103-109
22. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59:263-268; discussion 269
23. Bachand R, Scholz J, Pinaud M, et al. The effects of dexmedetomidine in patients in the intensive care unit setting. Intensive Care Med 1999; 25(Suppl 1):S160
24. Mantz J, Goldfarb G, Lehot J-J, et al. Dexmedetomidine efficacy for ICU postoperative sedation. Anesthesiology 1999; 91:197
25. Wang W, Li HL, Wang DX, et al. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: A randomized controlled trial. Crit Care Med 2012; 40:731-739
26. Ely EW, Siegel MD, Inouye SK. Delirium in the intensive care unit: An under-recognized syndrome of organ dysfunction. Semin Respir Crit Care Med 2001; 22:115-126
27. Di Salvo TG, O'Gara PT. Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients. Clin Cardiol 1995; 18:285-290
28. Sanders KM, Murray GB, Cassem NH. High-dose intravenous haloperidol for agitated delirium in a cardiac patient on intra-Aortic balloon pump. J Clin Psychopharmacol 1991; 11:146-147
29. Meyer-Massetti C, Cheng CM, Sharpe BA, et al. The FDA extended warning for intravenous haloperidol and torsades de pointes: How should institutions respond?. J Hosp Med 2010; 5:E8-E16
30. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007; 298:2644-2653
31. Riker RR, Shehabi Y, Bokesch PM, et al; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301:489-499
32. Ouimet S, Riker R, Bergeron N, et al. Subsyndromal delirium in the ICU. Evidence for a disease spectrum. Intensive Care Med 2007; 33:1007-1013
33. Pisani MA, Murphy TE, Araujo KL, et al. Factors associated with persistent delirium after intensive care unit admission in an older medical patient population. J Crit Care 2010; 25:1-7
34. Lindborg SR, Beasley CM, Alaka K, et al. Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients. Psychiatry Res 2003; 119:113-123
35. Loirat PH, Sapangenberg J, Dragsted I. Evaluation in intensive care. In: Management of Intensive Care: Guidelines for Better Use of Resources. Reis Miranda, Williams A, Loirat PH (Eds). Dordrecht, The Netherlands, Kluwer, 1990, pp 181-184
36. Hill MN. New targeted AHA research program: Cardiovascular care and outcomes. Circulation 1998; 97:1221-1222
37. Victora, CG, Habicht, JP, Bryce J. Evidence-based public health: Moving beyond randomized trials. J Inform 2004; 94:22
38. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996; 276:637-639
39. Pandharipande P, Cotton BA, Shintani A, et al. Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 2007; 33:1726-1731